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Blood flow controls bone vascular function and
osteogenesis
Saravana K. Ramasamy1,2, Anjali P. Kusumbe1,3, Maria Schiller1, Dagmar Zeuschner4, M. Gabriele Bixel1,
Carlo Milia5, Jaba Gamrekelashvili6, Anne Limbourg7, Alexander Medvinsky8, Massimo M. Santoro5,9,
Florian P. Limbourg6 & Ralf H. Adams1
While blood vessels play important roles in bone homeostasis and repair, fundamental
aspects of vascular function in the skeletal system remain poorly understood. Here we show
that the long bone vasculature generates a peculiar flow pattern, which is important for
proper angiogenesis. Intravital imaging reveals that vessel growth in murine long bone
involves the extension and anastomotic fusion of endothelial buds. Impaired blood flow leads
to defective angiogenesis and osteogenesis, and downregulation of Notch signalling in
endothelial cells. In aged mice, skeletal blood flow and endothelial Notch activity are also
reduced leading to decreased angiogenesis and osteogenesis, which is reverted by genetic
reactivation of Notch. Blood flow and angiogenesis in aged mice are also enhanced on
administration of bisphosphonate, a class of drugs frequently used for the treatment of
osteoporosis. We propose that blood flow and endothelial Notch signalling are key factors
controlling ageing processes in the skeletal system.
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O
steogenesis is critical for the maintenance of a healthy
and fully functional skeletal system. Loss of bone mass is
a major health issue associated with ageing and diseases
such as osteoporosis. During development of the mammalian
skeletal system, bone formation is tightly coupled to angiogenic
growth of blood vessels1–3. In the embryo, mesenchymal
condensations express vascular endothelial growth factor A
(VEGF-A), a master regulator of angiogenesis and ligand for
the receptor tyrosine kinase VEGFR2 (ref. 4). VEGF-A controls
growth plate morphogenesis, cartilage remodelling, blood vessel
invasion and ossification during skeletal development5–7.
Accordingly, bone is a highly vascularized tissue containing an
extensive vascular network of large vessels and capillaries.
Recently, we have identified a distinct capillary subtype
called type H, characterized by high expression of the markers
CD31 and Endomucin (Emcn), which couples angiogenesis
and osteogenesis in mice8,9. Osteoprogenitors, bone forming
mesenchymal cells identified by the expression of the
transcription factor Osterix, were selectively localized in
proximity to type H capillaries but were absent around
diaphyseal type L vessels (expressing lower levels of CD31 and
Emcn). Type H endothelial cells (ECs) secrete osteogenic factors
and maintain Osterixþ osteoprogenitors, but this crucial vessel
subtype declined in ageing animals, which was accompanied by
reduced osteoprogenitor numbers and loss of bone mass8,9. In the
bone of ovariectomized mice, a model of osteoporosis, type H
capillaries were also reduced10.
The effect of VEGF-A/VEGFR2 signalling in ECs is strongly
linked to the Notch pathway. While VEGF-A promotes EC
sprouting and proliferation, these processes are suppressed
by Notch receptors and the ligand delta-like 4 (Dll4)11,12.
Accordingly, reduced Dll4 expression or inhibition of Notch
triggered excessive EC sprouting and hyperproliferation in animal
models of developmental and tumour angiogenesis13–16.
Surprisingly, the activation of Notch was found to promote
angiogenesis in the bone endothelium, which involved the
paracrine (also termed ‘angiocrine’) release of signals by ECs that
are required for chondrocyte maturation, Sox9 expression and
VEGF expression9. In addition to molecular pathways, the
behaviour of ECs is strongly controlled by physical parameters
such as blood flow, which has roles in angiogenesis17, vessel
remodelling18 and numerous vascular pathologies19,20.
Haemodynamics is also coupled to the homeostasis of the skeletal
system21. Decreased blood flow was found to be associated with
reduced bone mass in elderly women22. Similarly, hypertension in
older men and women is associated with increased bone mineral
density23. Case studies reveal that reduced blood supply cause death
of bone cells in the osteonecrosis patients24. Additionally, active
blood supply is essential for callus formation during fracture
healing and repair25. Impaired blood vessel formation in fractures
can result in delayed bone healing and regeneration26. Thus, blood
flow has been linked to bone repair and maintenance27, but hardly
anything is known about the molecular processes coupling
haemodynamics to bone EC function and osteogenesis.
Here, we show that blood flow is crucial for the formation of
type H capillaries and angiogenic growth of the vasculature in
bone. Disrupted or pharmacologically reduced blood flow results
in defective angiogenesis and osteogenesis, and downregulates
Notch signalling in bone endothelium. We also find that reduced
blood flow and Notch activity in the bone endothelium of aged
mice affects angiogenesis and osteogenesis, which is reverted by
genetic approaches activating Notch in ECs. The sum of our work
highlights central roles of Notch signalling in bone endothelium
and its regulation by blood flow, which is relevant for age-related
bone loss and, potentially, for therapeutic approaches aiming at
the maintenance or restoration of bone mass.
Results
Vascular organization and flow pattern in bone. We
investigated the arrangement of arteries, veins and capillaries in
tibia to understand fundamental aspects of blood flow pattern in
bone. Immunostaining showed that CD31hi a-SMA-covered
Emcn-negative arteries and distal arterioles selectively connected
to CD31hi Emcnhi capillaries (type H) in the metaphysis and
endosteum, but not to diaphyseal sinusoidal (type L) vessels in
actively growing (3-week-old) long bone (Fig. 1a, Supplementary
Fig. 1a). This pattern indicates that arterial blood enters the long
bone at its distal ends as well as at the inner surface of compact
bone, and flows through type H capillaries into the highly
branched sinusoidal vasculature. From this intricate network,
blood is drained by a large Emcnþ CD31lo a-SMA-negative vein
with a lumen size of 4100 mm in the center of the diaphysis
(Fig. 1a–e; Supplementary Fig. 1b). To measure blood velocity in
type H and type L vessels of long bone, intravital imaging was
performed after dextran injection in living Flk1-GFP reporter
mice (Supplementary Movies 1 and 2). Consistent with the
hierarchical organization of the bone vasculature, line-scanning
analysis in living mice revealed that blood velocity in type H
capillaries was much higher (0.98±0.1mm s 1) than in type L
sinusoidal vessels (0.16±0.04mm s 1; Fig. 1f). Furthermore,
blood velocity dropped further after each vessel branch point
in the metaphysis until it finally reached the low velocity
characteristic for diaphyseal type L vessels (Fig. 1g). Accordingly,
calculated shear rate is significantly higher for type H capillaries
than in type L vessels (Supplementary Fig. 1c). The observed
differences in blood flow were also in line with the higher
transcription of the flow-regulated genes Pecam1, Nos3, Icam1
and Cdh5 in freshly isolated type H ECs than type L endothelium
(Supplementary Fig. 1d). These findings raised the possibility that
phenotypic differences between type H and L vessels (Fig. 1h)
might be linked to blood flow.
Blood flow regulates bone angiogenesis. To characterize the role
of haemodynamic forces in the generation of type H vessels that
mediate angiogenesis, we modulated blood flow in bone. We
analysed the 3-week-old tibial vasculature after ligation of the
femoral artery (Fig. 2a and Supplementary Fig. 2a), which is the
main vessel supplying blood to the lower limb28,29. At 48 h
post surgery (hps), the inhibition of local blood flow resulted in
the strong reduction of columnar vessels and endothelial
bud structures in proximity of the growth plate (Fig. 2b and
Supplementary Fig. 2b) without promoting endothelial apoptosis
(Supplementary Fig. 2c). At an earlier time point after surgery
(16 hps), profound anastomoses of buds could be observed
in tibial blood vessels near the growth plate (Supplementary
Fig. 2d).
Prazosin is an inhibitor of the alpha 1-adrenergic receptor that
reduces blood pressure via relaxation of vascular smooth muscle
and thereby increases flow into peripheral capillaries30. Prazosin
has been recently shown to reduce bone formation in mice, which
has been linked to alpha 1-adrenoreceptor signalling in
osteoblasts31. We found that administration of Prazosin for 2
weeks led to significantly reduced blood flow in bone (Fig. 2c),
which might result from the diversion of flow into other organs.
The observed flow reduction was accompanied by decreased
abundance of endothelial buds near the growth plate and of the
number of metaphyseal CD31hi type H vessels (Fig. 2d–f)
suggesting decreased angiogenesis. Analysis of EdUþ cells on
Prazosin treatment showed decreased proliferation of ECs (Fig. 2g
and Supplementary Fig. 2e). The expression of flow-regulated
genes was significantly downregulated in freshly isolated bone
ECs following Prazosin treatment (Supplementary Fig. 2f).
Similar phenotypic changes in blood vessels were observed in
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mice treated with another flow-reducing drug, Clonidine
(Supplementary Fig. 2g,h). Together, these data indicate that
angiogenesis in bone is impaired by alterations in blood flow.
Mode of angiogenesis in bone. As pharmacological and surgical
impairments in blood flow led to profound morphological
changes in type H vessels, we investigated the mode of blood
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Figure 1 | Blood flow dynamics in long bone. (a) Tile scan image of tibial vasculature immunostained for Emcn (red) and a-smooth muscle actin (green).
Arteries covered by a-SMAþ cells connect (arrows) to metaphyseal (mp) type H vessels near growth plate (dashed lines, gp). Sinusoidal type L vessels
connect to central large vein (yellow arrowhead). (b,c) Confocal images of 4-week-old metaphysis near growth plate (gp) (b, top panels) or diaphysis (dp)
(c, top). CD31þ (green) Emcn- (red) arteries terminate in CD31þ Emcnþ type H vessels in the metaphysis (mp) and endosteum (es) but not in type L
vessels in diaphysis (dp). Blue arrows in Emcn-stained (red) overview images (bottom panels) illustrate blood flow direction from metaphyseal vessel
columns (b) and endosteum (c) into the adjacent sinusoidal network and veins. (d) Maximum intensity projection of transversal sections of 4-week-old
tibia immunostained for a-SMA (green) and Emcn (red). Sinusoidal type L vessels (arrowheads) connect to a large central vein (v). Multiple smooth
muscle-covered CD31þ Emcn-arteries cross the diaphysis. Dashed lines mark compact bone. (e) Diagram of arterial (green arrows), type H (red arrows)
and sinusoidal/venous flow (blue arrows) in murine long bone. (f) Graph showing blood velocities calculated from line scanning of type H and type L
vessels after Dextran (2,000,000Da) injection. Data represent mean±s.d. (n¼ 5 biological replicates). P values, two-tailed unpaired t test. (g) Overview
image and representative line scans showing blood velocities in 2-week-old long bone. Note decreasing velocity of erythrocytes at each branch point
(represented as 1, 2, 3, 4) at the interface between columnar type H (right) and diaphyseal type L vessels (left). Data represent mean±s.d. (n¼ 5
biological replicates). (h) Confocal images of CD31 (green) expression in the metaphysis and diaphysis of 4-week-old tibia. Note differences in CD31 levels.
Scale bars are as indicated in the respective images. DAPI (blue) is used for counterstaining of nuclei.
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vessel growth in postnatal bone. While the columnar organization
is a characteristic feature of metaphyseal type H vessels,
these columns were interconnected by distal, loop-like arches.
Bud-shaped protrusions emerging from those arches were
localized in close proximity of hypertrophic growth plate
chondrocytes (Fig. 3a). Their juxtaposition to hypertrophic
chondrocytes, a known source of VEGF-A (ref. 5), suggested that
buds represent the leading edge of the growing vasculature, which
would make them functionally equivalent to endothelial tip cells
and sprouts observed in other organs32,33. Accordingly, the length
of columns and the abundance of buds increased during postnatal
bone growth (Supplementary Fig. 3a–c). In adult (12-week-old)
long bone, arches remained as the most prominent distal vessel
structure, while the abundance of buds was strongly decreased
(Fig. 3b; Supplementary Fig. 3b). In line with the previously
reported reduction of type H vasculature in long bone of aged
mice8, CD31hi vessel arches in 80-week-old mice were sparse and
spanned longer distances than in adults, while buds were almost
completely absent (Fig. 3b).
To gain insight into the dynamics of blood vessel formation in
postnatal long bone, we developed an intravital live imaging
technique using the endothelium-specific Flk1-GFP reporter mice
to monitor blood vessel growth in long bone. The observation of
green fluorescent protein (GFP)þ ECs next to the growth plate
demonstrated the emergence of buds from arches (Fig. 3c and
Supplementary Movie 3). Static imaging and ultrastructural
analysis by scanning electron microscopy indicated that
lumenized buds carried short filopodia, which connected to the
surrounding chondrocyte matrix (Fig. 3d,e and Supplementary
Fig. 4a). Other buds lacked visible filopodia and were found in
proximity of intact chondrocytes (Fig. 3e and Supplementary
Fig. 4b–d), suggesting that they were not actively extending at
the time of analysis. Mosaic fluorescent labelling of ECs by
tamoxifen-induced, EC-specific recombination of R26-Confetti
reporter mice indicated that buds were composed of multiple cells
enclosing a luminal space (Fig. 3f and Supplementary Fig. 4e,f).
Dynamic and static imaging approaches also established that
new arches were formed through the anastomoses of two
neighbouring bud structures (Fig. 3g–i and Supplementary
Movie 4). Thus, arches and buds are dynamic structures that
are formed during active angiogenesis and mediate vessel growth
in long bone. Due to reduced or absent endothelial budding after
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Figure 2 | Changes in blood flow impair bone angiogenesis. (a) Schematic representation of unilateral femoral artery ligation in 3-week-old mice. Results
compare operated (ipsilateral) legs with contralateral controls. (b) Representative confocal images showing CD31 (green) and Emcn (red) immunostaining
of tibia from ligated and contralateral side at 48 h post surgery (hps). Note decline in vascular front structures, buds and columns on ligation. Insets show
vessel buds (blue arrowheads) on the contralateral side and appearance of pointed, sprout-like structures (white arrowheads) after ligation. (c) Analysis of
blood flow in Prazosin-treated tibia compared with saline-treated control. Data represent mean±s.d. (n¼4 biological replicates). P values, two-tailed
unpaired t test. (d,e) Confocal images of 4-week-old Prazosin-treated and control tibial metaphysis immunostained for Emcn (red; d) or CD31 (green; e).
Insets in d show vessel buds (blue arrowheads), which appeared collapsed (white arrowheads) after Prazosin treatment. CD31 (green) expression was
decreased in Prazosin-treated animals (e). (f) Flow cytometric quantification of tibial type H ECs after treatment with Prazosin or control (saline).
(g) Quantitation of EdUþ ECs present in the metaphysis of Prazosin-treated and control mice. Data represent mean±s.e.m. (n¼4 biological replicates).
P values, two-tailed unpaired t test.
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the completion of postnatal bone growth, vessel arches remain as
the predominant distal vascular structure in adult and aged long
bone (Fig. 3b). These results also indicate that the defective
angiogenesis observed under flow-modulated conditions is due to
defective bud formation and anastomosis at the vascular front
(Fig. 2b and Supplementary Figs 2b and 4g).
Flow-mediated coupling of angiogenesis and osteogenesis.
As angiogenesis in bone is tightly coupled with osteogenesis,
we investigated whether modulation of blood flow would affect
bone formation. Both femoral artery ligation and Prazosin
treatment led to significant reductions in Osterix-expressing
osteoprogenitors (Fig. 4a–c and Supplementary Fig. 5a,b).
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(d) SEM images of blood vessel (BV) next to chondrocytes (Ch) in 4-week-old tibia with distal arch (A) and bud (B; arrowhead). Right panel shows higher
magnification of inset with bud emerging from arch. (e) Merged confocal and differential interference contrast (DIC) image showing distal vessel buds (B)
genetically labelled by GFP (green). Arrow indicates a filopodia-bearing endothelial bud displacing an apoptotic chondrocyte, arrowhead points at filopodia-
free bud next to intact chondrocyte. (f) 4-week-old Cdh5-CreERT2 R26-Confetti double transgenics at 7 and 21 days post injection (dpi) showing high degree
of mosaicism in endothelial columns, arches and buds. (g) Schematic illustration of vessel growth in long bone. Invading vessels buds (B) displace apoptotic
growth plate chondrocytes (c) and, through anastomosis, generate new arches (A), from which new buds can emerge. (h) Representative confocal images
showing contact formation and anastomosis (arrows) of CD31þ (green) vessel buds in 4-week-old tibia. Note red presence of Ter-119þ RBCs (red) in
buds and forming vessel arches. (i) Still images (time indicated) from movie showing anastomosis (arrows) of 2 buds (arrowheads in left image) in
10-day-old Flk1-GFP (green) metatarsal. Arrows show the disappearance of junction between anastomosing buds at later time points.
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Moreover, micro-CT analysis confirmed that Prazosin
administration led to loss of mineralized bone (Fig. 4d,e and
Supplementary Fig. 5c). This is likely to reflect altered bone
formation rates, as osteoclast numbers were not significantly
changed (Supplementary Fig. 5d). Defective blood flow also led to
reduced expression of pro-osteogenic factors in freshly sorted
bone ECs (Fig. 4f).
Next, we investigated the molecular link between blood flow
and angiogenesis in bone. Pecam1/CD31 is highly expressed by
ECs in type H arch and bud structures (Fig. 1h) and was shown
to have mechanosensory activity34,35. To evaluate a potential
involvement of CD31 in the generation of specific vessel
subtypes, we analysed the vasculature in long bone of Pecam1
knockout mice36. However, in spite of absent CD31 expression,
these mutants did not show defects in bone angiogenesis
(Supplementary Fig. 6a). Likewise, Osterix-expressing cells were
unaffected in Pecam1-deficient mice (Supplementary Fig. 6b)
indicating that this molecule is dispensable for physiological bone
angiogenesis and osteogenesis.
Flow modulates endothelial Notch signalling. Notch signalling
in bone endothelium promotes blood vessel growth and has been
shown to couple angiogenesis and osteogenesis9. Immunostaining
showed that Dll4, the critical Notch ligand in bone ECs, was
highly expressed on the endothelium of arteries and distal type
H buds, which was independent of PECAM1/CD31 expression
(Supplementary Fig. 6c). The transcription factor RBP-Jk is an
essential regulator of Notch-induced gene expression inside and
outside the vasculature37–39, and Cdh5(PAC)-CreERT2-mediated
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inactivation of the Rbpj gene led to defective growth and severe
dilation of metaphyseal vessels in the resulting RbpjiDEC
mutants9. Consistent with these morphological alterations,
transcript analysis of sorted RbpjiDEC bone ECs revealed a
downregulation of the flow-modulated genes Klf2, Nos3 and
Pecam1 relative to control littermates (Supplementary Fig. 7a).
Conversely, EC-specific and inducible (Cdh5(PAC)-CreERT2-
controlled) overexpression of the active Notch1 intracellular
domain (NICD), which was recently shown to enhance artery
formation in long bone40, led to the upregulation of Klf2, Nos3
and Pecam1 in ECs (Supplementary Fig. 7a). Thus, Notch
signalling controls the expression of flow-controlled genes, which
presumably reflects morphological alterations in the bone
vasculature.
Other results indicate that the expression of Notch pathway
components and Notch signalling in ECs are regulated by flow.
Prazosin treatment led to a strong reduction of Dll4 expression by
bone ECs at the transcript and protein level (Fig. 5a,b). Likewise,
mRNAs for several Notch pathway target genes were significantly
downregulated in freshly isolated bone ECs from Prazosin-treated
animals (Fig. 5b). Tibial ECs from femoral artery ligation
experiments (16 hps) also showed reduced expression of Dll4
(Supplementary Fig. 7b) and other Notch downstream target
genes (Fig. 5c). Conversely, when mice were treated for 48 h with
angiotensin II to increase blood flow, sorted bone EC showed
increased expression of Notch target genes (Supplementary
Fig. 7c). The exposure of cultured ECs to laminar flow increased
the level of NICD protein and upregulated the expression of
known Notch target genes (Supplementary Fig. 7d,e). Together,
these data indicate that endothelial Notch signalling is controlled
by blood flow.
Blood flow in aged mice bones. Skeletal ageing is associated with
decreased bone formation and loss of type H vasculature8. Gene
expression analysis in freshly isolated bone ECs from aged mice
revealed that transcript levels for numerous Notch target genes
were strongly downregulated (Fig. 5d,e). Measurements using
radiolabelled microspheres in rats have previously shown that
blood flow in aged bone is decreased relative to young adult
animals41. Our own analysis also indicated a remarkable decline
in blood flow in long bone of aged mice relative to young animals
(Fig. 5f). These data suggest that the reductions in both Dll4
expression and Notch signalling in ECs of the aged bone
vasculature might be induced or enhanced by changes in blood
flow. To further investigate the link between endothelial Notch
activity, blood flow and organization of the bone vasculature,
Prazosin was administered to transgenic mice overexpressing
active NICD of Notch1 (NICDiOE-EC)42 in ECs. Remarkably, bud
structures at the vascular growth front were preserved in
Proazosin-treated NICDiOE-EC gain-of-function mutants (Fig. 5g
and Supplementary Fig. 7f). Thus, Notch activation in bone ECs
was sufficient to overcome defects caused by administration of
Prazosin.
Next, we addressed whether EC-specific Notch activation
would be also sufficient to overcome age-related changes in the
bone vasculature. For this purpose, NICDiOE-EC mutants at the
age of 55–65 weeks received injections of tamoxifen before
analysis 42 days later (Fig. 5h). This approach led to the
reappearance of type H vessels and formation of Dll4-positive
endothelial buds in the NICDiOE-EC but not in the control
metaphyseal region (Fig. 5i,j and Supplementary Fig. 8a,b).
A second strategy involved EC-specific inactivation of the
gene encoding Fbxw7 (Fbxw7iDEC)43, which mediates the
polyubiquitination and proteasomal degradation of active
Notch. Tamoxifen treatment of aged Fbxw7iDEC mice also lead
to the reappearance of CD31hi capillaries together with
Dll4-positive vessels buds, which were absent in control
littermates (Fig. 5h and Supplementary Fig. 8c). Changes in
the vasculature of aged NICDiOE-EC and Fbxw7iDEC mutants
were accompanied by significant increases in Osterix-expressing
osteoprogenitors (Fig. 5k; Supplementary Fig. 8d,e) and enhanced
bone formation, as seen by micro-CT analysis (Supplementary
Fig. 9a–d). The formation of new bone also involved
enhanced bone remodelling indicated by the increased
abundance of osteoclasts (Supplementary Fig. 9e). Thus,
EC-specific Notch-mediated reactivation of type H vessels in
aged mice can promote both angiogenesis and osteogenesis
leading to improved bone mass.
Bisphosphonate increases bone blood flow and angiogenesis.
Bisphosphonates are commonly used medications for osteo-
porosis treatment. While the inhibition of hydroxyapatite
breakdown by osteoclasts is the main mechanism of action
for bisphosphonates, it has been proposed that this class of
antiresorptive drugs also acts on other cell types and inhibits
apoptosis of osteoblasts and osteocytes44,45. As age-related
changes in bone mass in mice strongly correlate with
alterations in the abundance of CD31hi vessels in bone8, blood
flow, EC proliferation and the presence of endothelial buds
(Fig. 6a), we tested whether bisphosphonate treatment would
affect any of these vascular parameters. Indeed, administration of
Alendronate to aged mice (2mg kg 1) twice a week for 6 weeks
led to substantial increases in type H vessels and Osterixþ
osteoprogenitors relative to control animals (Fig. 6b,c).
Alendronate also induced the reappearance of vessel buds in
the metaphysis and expression of the Notch ligand Dll4 (Fig. 6d).
Expression analysis of freshly sorted ECs from aged bone showed
that Alendronate significantly increased transcript levels of
several Notch target genes (Fig. 6e), whereas such changes were
not induced by Alendronate in cultured primary bone ECs
(Supplementary Fig. 9f). In addition, Alendronate treatment led
to significantly increased blood flow (Fig. 6f). To understand
whether the increase in blood flow on Alendronate treatment
precedes or succeeds new blood vessel formation, we measured
flow in the bone vasculature after short treatment with
bisphosphonate. Following three injections of Alendronate
every 12 h, 3-week-old mice showed significantly increased
perfusion of the bone vasculature at 30min after last injection
(Fig. 6g). Taken together, these data argue that bisphosphonate
treatment can trigger a complex response in bone, which involves
enhancements in blood flow, activation of endothelial Notch
signalling and vessel growth.
Discussion
In addition to their conventional role as a conduit system
for blood circulation, there is increasing evidence that vascular
cells generate specialized microenvironments supporting stem
and progenitor cells. In bone, the local vasculature provides
niches for haematopoietic stem cells and thereby regulates
haematopoiesis46–49. Likewise, bone formation and fracture
healing are controlled by blood vessels and EC-derived
molecular signals8,9,50,51. The osteogenesis-promoting effect of
the bone vasculature in physiological settings was recently
attributed to the type H capillary subset, which is characterized
by high expression of the cell adhesion protein CD31/PECAM1
and association with perivascular Osterix-positive cells8,9.
Indicating potential roles in disease and therapy, CD31hi
Emcnhi capillaries were decreased in ovariectomy-induced
osteoporotic mice, whereas the administration of cathepsin K
inhibitor, which impairs bone resorption, led to an increase in
CD31hi Emcnhi vasculature10.
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Bone growth is controlled by genetic programs and physical
factors such as mechanical loading52,53. Chondrogenesis,
chondrocyte differentiation, VEGF expression in the growth
plate and angiogenesis are also influenced by mechanical
signals5,54,55. Our current study unravels the cellular basis of
angiogenic vessel growth in the metaphysis by type H capillaries
in direct proximity of growth plate chondrocytes with live
imaging, which revealed that new anastomotic connections
(arches) are formed by fusion of multicellular vessel buds.
Blood flow is required for the formation and anastomotic fusion
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of buds in the vascular front, type H vessel formation and
angiogenesis in bone. Thus, CD31hi Emcnhi capillaries are not
only connecting directly to distal arterioles and are therefore
perfused at higher velocity than the highly branched sinusoidal
network, but blood flow also regulates fundamental properties of
the bone vasculature and its ability to promote osteogenesis. The
relationship between blood pressure, flow in the skeletal system
and bone mass in the clinical context is complex and linked to
numerous factors such as nutrient delivery, the regulation of local
metabolism or the influx of calcium and phosphate21,27.
Decreased blood flow in bone has been reported in pathological
conditions such as osteoporosis22 and osteonecrosis24. Likewise,
ageing is not only associated with bone loss but also with reduced
blood flow in the skeletal system41. Our new findings link these
flow and ageing-related changes to reduced Notch activity in ECs.
While endothelial Notch signalling is known to suppress vessel
growth in a wide range of organs and model organisms13,56,57, the
pathway acts as a strong stimulator of angiogenesis and thereby
osteogenesis in the skeletal system9. The expression of Notch
pathway genes and bone formation were strongly reduced by
treatments disturbing normal blood flow or in aged animals,
whereas the reactivation of Notch signalling in ECs was sufficient
to restore local angiogenesis and bone formation (Fig. 7).
A number of reports addressing the relationship between flow
and Notch signalling suggest complex and, potentially, context-
dependent interactions. Notch pathway genes are highly
expressed by arterial ECs, which are exposed to higher flow
rates and shear stress, whereas venous expression is low or
undetectable58,59. This is consistent with numerous studies
reporting Notch activation in blood vessel ECs in response to
flow and laminar shear stress60–62. In contrast, loss of blood flow
led to increased vascular Notch signalling in the vasculature of
zebrafish embryos63. Notch facilitates vessel constriction during
the regression (pruning) of capillaries64, but Notch activity is also
required for nitric oxide induction and vasodilation in response
to ischaemia in the adult vasculature65. Furthermore, Notch
activation is a hallmark of arteriovenous malformations and
constitutive activation of Notch4 has been shown to induce the
enlargement of capillary vessels into arteriovenous shunts66.
We propose that Notch controls blood flow and expression of
flow-controlled genes in the bone endothelium presumably by
controlling vascular morphology, angiogenic growth and the
formation of arteries/arterioles in bone. Whether such effects
might also involve the release of vascular autocoids (that is, local
acting factors) such as nitric oxide, which was shown to reduce
bone resorption67, or pro-anabolic molecules that promote bone
formation, such as calcitonin gene-related peptide68, remains to
be investigated. Notch signalling also has important
cell-autonomous roles in the osteoblast lineage and preserves
mesenchymal progenitors by preventing excessive differentiation
of these cells69,70. Notch activation in mature osteocytes triggers a
strong skeletal anabolic response in adult mice, which is sufficient
to rescue age-associated and ovariectomy-induced bone loss71.
As osteocyte processes physically interact with the vascular
endothelium72, it would be worthwhile to investigate whether
different cell types communicate through direct Notch-ligand
interactions.
Our findings also support that Notch activity and pathway
gene expression in ECs depend on flow, which is therefore critical
for the formation of type H capillaries, the formation of
endothelial buds and thereby the expansion of the growing
vasculature, and Notch-mediated coupling of angiogenesis and
osteogenesis. Accordingly, reduced blood flow in the ageing
organism might be a cause of reduced endothelial Notch activity,
which, in turn, might contribute to age-related bone loss.
Supporting this concept, the reactivation of Notch signalling in
the ageing vasculature was sufficient to induce local growth of
type H capillaries, which was accompanied by the expansion
of vessel-associated Osterixþ osteoprogenitors and formation of
mineralized bone.
Remarkably, treatment of mice with bisphosphonate, the class
of drugs that is commonly used in humans to prevent the loss of
bone mass, also led to the induction of endothelial Notch
expression, the emergence of CD31hi Emcnhi capillaries and
increased blood flow. While it remains unclear whether the effect
of Alendronate on bone ECs is direct or mediated by changes in
other cell types, our findings nevertheless indicate that properties
of the local vasculature might play a far more central role in the
regulation of bone mass than previously appreciated.
Methods
Age groups and genetically modified mice. C57BL/6 J males were used for all
experiments involving wild-type mice and pharmacological treatments, whereas
both males and females animals were analysed in the genetic experiments. Mice at
the age of 2–4 weeks and 453 weeks were chosen for young and aged groups,
respectively, unless specified otherwise. For Prazosin treatment, C57BL/6 J mice
were given 0.5mg kg 1 body weight dose every second day from P10 to P20 before
they were killed and analysed at P24. For Alendronate treatment in aged mice,
75-week-old C57BL/6 J mice were given 2mg kg 1 body weight dose twice a week
for 5 weeks and killed on the 6th week. Mosaic multi-colour labelling of ECs was
achieved by combining R26R-Confetti reporter73, which can express four different
fluorescent proteins in a stochastic and Cre-dependent fashion, with Cdh5(PAC)-
CreERT2 transgenics8,74 expressing tamoxifen-inducible CreERT2 specifically in
ECs. 4-Hydroxy tamoxifen was administered (100 mg) by five consecutive, daily
injections, which was followed by analysis of the bone vasculature at 7 or 21 days
after the last injection, as indicated. For Fbxw7 deletion in the vasculature of aged
mice, mice carrying loxP-flanked Fbxw7 gene (Fbxw7 floxed)43 were interbred
with the Cdh5(PAC)-CreERT2 line. Fbxw7floxed/floxed Cdh5(PAC)-CreERT2 T/þ
males were interbred with Fbxw7floxed/floxed females to generate litters with
Fbxw7floxed/floxed Cdh5(PAC)-CreERT2 T/þ (Fbxw7iDEC) mutants and Cre negative
Fbxw7floxed/floxed (control) littermates. To induce Cre-mediated gene inactivation,
Figure 5 | Flow positively regulates endothelial Notch signalling in bone. (a) Dll4 (green) immunostaining of Prazosin-treated and control tibia sections.
(b,c) qPCR analysis of Dll4, Hes1, Hes5, Hey1, Hey2 and Jag1 expression (normalized to Actb) in ECs sorted from Prazosin-treated or control long bone
(b) and from ipsilateral (operated) and contralateral sides of femoral artery ligated (16hps) limbs of mice (c). Data represent mean±s.d. (n¼ 5 biological
replicates). P values, two-tailed unpaired t test. (d) qPCR analysis of Dll4, Hes1, Hes5, Hey1, Hey2 and Jag1 expression (normalized to Actb) in ECs
sorted from 4 (young) and 85-week-old (old) long bone. Data represent mean±s.d. (n¼ 5 biological replicates). P values, two-tailed unpaired t test.
(e) Representative confocal images showing the metaphysis region near the growth plate (gp, dashed line) in young (4 week) and aged (85 week) tibia
immunostained for Emcn (red) and Dll4 (green). (f) Blood flow measurements in young and old mice show reduced flow upon ageing. Data represent
mean±s.d. (n¼ 5 biological replicates). P values, two-tailed unpaired t test. (g) Maximum intensity projections of tibial sections from NICDiOE-EC
(Notch gain-of-function) mice and littermate controls treated with saline (control) and Prazosin, immunostained for CD31 (green) and Emcn (red).
Blue arrowheads indicate buds and arches, white arrowheads mark defective buds in the vascular front. (h) Experimental scheme of tamoxifen
administration to aged transgenic mice for EC-specific activation of Notch signalling. (i) Confocal images of aged NICDiOE-EC and littermate control tibiae
immunostained for CD31 (green) and Emcn (red). Note increase in CD31þ vessels and buds (arrows) near NICDiOE-EC growth plate (gp, dashed blue line).
(j) Quantification of bud structures in the vascular front of aged NICDiOE-EC and littermate control tibiae. Data represent mean±s.d. n¼4 in three
independent experiments. P values, two-tailed unpaired t test. (k) Confocal images of the metaphyseal region of aged NICDiOE-EC and littermate control
tibiae immunostained for Osterix (Osx, white). Nuclei, DAPI (blue).
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aged (41 year) mutant and control mice were injected with 1,000 mg tamoxifen
(Sigma, T5648) intraperitoneally every day for 5 days. All mice were rested for 16
days before subjecting them to a second round of 5 tamoxifen injections. After
another 16-day resting period, mice were analysed by collecting femur and
tibia after euthanasia. For EC-specific overexpression of the active NICD,
Gt(ROSA)26Sortm1(Notch1)Dam/J mice42 carrying a Cre-inducible transgene for
NICD overexpression and Cdh5(PAC)-CreERT2 transgenics were interbred.
Tamoxifen administration (see injection schedule for aged mice above) was used to
generate CreERT2-positive (NICDiOE-EC) Notch gain-of-function mutants and
corresponding Cre-negative control littermates.
Experiments involving animals were performed following protocols approved
by local animal welfare boards and official institutions (LAVES Lower Saxony,
LANUV North Rhine Westphalia).
Femoral artery ligation. Male 3-week-old C57BL/6 J mice were subjected to
permanent femoral artery ligation28. Mice were anaesthetized by intraperitoneal
injection of ketamine and xylazine before surgery. The femoral artery was ligated
distal to the origin of the deep femoral artery and proximal to the popliteal artery.
Blood flow measurements in mouse feet were performed on 37 C heated pads
before and immediately after surgery and on post-operative 16 and 48 h using a
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laser Doppler perfusion imager (PIM II, Perimed, Sweden). Animals were
euthanized at 16 or 48 hps and tibias were collected for analysis.
Immunohistochemistry. Freshly dissected tibiae were collected from wild type,
mutant mice and their control littermates. Bone were processed and imaged as
reported earlier8,9. The following primary antibodies were used: Emcn (sc-65495,
Santa Cruz, diluted 1:100), Pecam1 conjugated to Alexa Fluor488 (FAB3628G,
R&D Systems, 1:100), Pecam1 (553370, BD Pharmingen, 1:100), Osterix
(sc-22536-R, Santa Cruz, 1:200), alphaSMA-Cy3 (C6198, Sigma, 1:100),
Calcitonin receptor (ab11042, Abcam, 1:75), Dll4 (AF1389, R&D Systems, 1:100),
Biotin-conjugated CD45 (553077, Becton Dickinson, 1:100) and Ter-119
(MAB1125, R&D Systems, 1:100). After sections had been washed with PBS for
three times, the following secondary antibodies were used: Anti-rat Alexa Fluor 594
(Invitrogen; A21209, 1:400), anti-rabbit Alexa Fluor 546 (Invitrogen; A11035,
1:400), anti-goat Alexa Fluor 488 (Invitrogen; A11055, 1:400) and streptavidin
Alexa Fluor 488 (Invitrogen; S11223, 1:400). Immunofluorescent stainings were
analysed at high resolution with a Zeiss laser scanning confocal microscope, LSM780.
Proliferating cells were labelled by injecting mice intraperitoneally with EdU
(Invitrogen) 3 h before euthanasia. Mice were killed; bones were collected and
processed following the protocol mentioned before. For immunostaining EdU
using Click-iT chemistry, manufacturer’s protocols were followed.
Image acquisition and analysis. Z-stacks of images were processed and 3D
reconstructed with the Imaris software (version 7.00, Bitplane). Imaris, Image J,
Zen (Carl Zeiss), Photoshop and Illustrator (Adobe) softwares were used for image
and movie processing in compliance with Nature’s guide for digital images. For all
quantifications, a region of 300–400 mm from growth plate towards the caudal
region was selected in the metaphysis. All quantifications were done with Image J
software on high-resolution confocal images.
Quantitative RT–PCR. For transcript analysis, fresh bone samples were crushed
and digested with Collagenase to prepare a single-cell suspension. Pure ECs were
sorted by flow cytometry using a FACSAria (BD Biosciences) directly into the
lysis buffer of RNeasy Mini Kit (Qiagen). Total RNA was isolated following the
manufacturer’s protocol and, subsequently, a total of 100–500 ng RNA was used to
generate cDNA with the iScript cDNA Synthesis System (Bio-Rad). Further,
quantitative PCR (qPCR) was performed using TaqMan gene expression assays on
an ABI PRISM 7900HT Sequence Detection System. TaqMan Gene Expression
Master Mix (Applied Biosystems) was used to perform qPCR for the FAM-
conjugated TaqMan probes Pecam1, Nos3, Dll4, Jag1, Hes1, Hey1, Hey2, Hes5,
Angpt2, Cdh5, Sp7, Bglap, Tgfb1, Tgfb2, Tgfb3, Bmp2, Bmp4, Fgf1, Pdgfb and
Wnt10b commercially available at Life Technologies (Thermo Fisher Scientific).
All the gene expression assays were normalized using endogenous VIC-conjugated
Actb probes. For the analysis of Bgalp and Sp7 expression, RNA was isolated
from whole-bone samples. Freshly dissected bones were immediately flushed
(to remove haematopoietic cells), crushed and lysed in lysis buffer for 15min
before proceeding for RNA isolation, cDNA preparation and qPCR analysis as
described above.
Bone blood flow measurements. Blood flow measurements were performed in
tibia of mice following a previously published protocol75. Briefly, anaesthetized
mice were given intracardiac injection of fluorescent microspheres (Invitrogen
FluoSpheres 15 mm, cat. no. F8842). Mice were killed after 1min and bones (tibia,
femur and sternum) were collected immediately. After decalcifying the bones for
24–48 h, they were subjected to ethanolic lysis for 1–2 days in a shaker incubator at
37 C, 75 r.p.m. and protected from light. Then the samples were run through
filtration unit to collect microspheres in a nylon membrane. Finally, spheres were
collected in 1ml of Cellosolve acetate and fluorescence intensity is quantified using
microplate reader.
Intravital imaging. 10-day-old Flk1-GFP knock-in mice were anaesthetised
using ketamine and xylazine. Following the careful dissection of skin and muscle
covering the metatarsals, mice were placed on stage of a Zeiss LSM780 laser
scanning confocal microscope. Depending on the region of interest, location of
metaphysis or diaphysis was selected for further imaging. After 1 h, the animals
were continuously provided with isoflurane and oxygen combinations. Blood vessel
growth was monitored for 6–10 h continuously with every 5–10min scanning
depending on experimental requirements. Mice were euthanized with an overdose
of anaesthetics after the experiment. All the images were analysed using ZEN 2010
and Imaris software platforms.
Quantification of blood flow speed and shear rate. Movies of red blood cell
(RBC) movement in the bone vasculature were captured in the anaesthetized
Flk1-GFP mice after dextran (2,000 kDa) injection using LSM780 confocal
microsocope with the scan speed of 120 frames per second. Line scan analysis
was performed to trace the displacement of RBCs and calculate the speed of
erythrocytes based on the distance RBCs displaced per time unit (¼ number
of frames 1/120 s). Using this blood flow speed, shear rate was calculated
considering blood vessels as straight cylinders and blood as an ideal Newtonian
fluid with constant viscosity. Under these conditions, shear rate (g) experienced by
ECs lining a blood vessel is 8v/d where v is the blood speed and d is the diameter of
the blood vessel.
Flow cytometry. Freshly isolated bone samples were cleaned thoroughly to
remove the adherent muscles and then crushed in ice-cold PBS with a mortar
and pestle. Whole bone marrow was digested with Collagenase at 37 C for
20min. After washing and filtering, single-cell suspensions were subjected to
immunostaining. Cells were stained with Emcn (sc-65495, Santa Cruz, 1:100)
antibody for 45min. After washing in PBS, cells were stained with anti-rat APC
(Jackson laboratories, 712-136-153, 1:50) and CD31-conjugated with Alexa Fluor
488 (R&Dsystems, FAB3628G, 1:50) for 45min. After washing, data were acquired
and analysed on BD FACSVantage cytometer (BD Biosciences).
Micro-CT analysis and histomorphometry. Tibiae were collected from mutants
and their littermate controls, or from treated mice and sham controls. Bones
were cleaned thoroughly to remove surrounding soft tissues and fixed in 4%
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paraformaldehyde. The fixed tibiae were analysed using micro-CT (mCT 35) and
software IPL V5.15 at Scanco Medical AG, Switzerland. A voxel size of 12 mm was
chosen in all three spatial dimensions. For each sample, 148 from 232 slices were
evaluated covering a total of 1.776mm at a voltage of 70 kVp, intensity 114 mA and
integration time 1,200ms. Osteoclast number/bone perimeter (No. Oc./B. Pm)
were calculated based on Calcitonin receptor staining of bone sections.
Electron Microscopy (SEM and transmission electron microscopy). Tibiae
from 21-day-old mouse were dissected, cut open on their distal part and
submerged in 4% paraformaldehyde, 0.5% glutaraldehyde, 2mM MgCl2,
2mM CaCl2 in 0.1M cacodylate buffer, pH 7.4, under agitation for 2 h at room
temperature. Samples were fixed further for 1 h in 2% paraformaldehyde, 2%
glutaraldehyde, 2mM MgCl2, 2mM CaCl2 in 0.1M cacodylate buffer, pH 7.4 and
overnight at 4 C. Next, bones were then decalcified over 5 days (with one change
of solution after 2 days) in 5% EDTA in 0.1M cacodylate buffer, pH 7.4 under
rotation at 4 C. Subsequently, 100 mm sections were generated with a vibratome
(VT 1200, Leica, Viennna, Austria). Sections were post-fixed in 1% OsmO4,
containing 1.5% KFeCN in 0.1M cacodylate buffer, pH 7.4. Sections for
scanning electron microscopy (SEM) analysis were glued on coverslips with 4% low
melting point-agarose and dehydrated stepwise in ethanol. Finally they were critical
point dried (CPD 300, Leica, Vienna, Austria) with 35 exchanges against CO2.
Before examination, SEM samples were processed by sputtering with platinum and
carbon. Analysis was performed at a Zeiss-Leo-SEM (NanoAnalytics, Mu¨nster,
Germany). Vibratome-sections chosen for transmission electron microscopy were
dehydrated and embedded flat in epon. Areas of interest were ultrathin (60 nm)
sectioned and placed on a formvar-filmed single-copper grid. Samples were
counterstained with uranyl-acetate and lead, and imaged at a transmission electron
microscope at 80kV (Tecnai12-biotwin, FEI, Eindhoven, Netherlands).
Experiments using cultured ECs. Human umbilical vein ECs were obtained
from Lonza (cat. No. CC-2529). Primary ECs were cultured in M199 medium
supplemented with 1:600 bovine brain extract (Lonza, Braine-l’Alleud, Belgium),
a cocktail of penicillin, streptomycin and Amphotericin B (Invitrogen, Life
Technologies, Ghent, Belgium), 10 kU heparin (Sigma-Aldrich, Bornem, Belgium)
and 20% FBS (Merk Millipore, Berlin, Germany). Cells were seeded and propagated
on 0.1% gelatin (Sigma-Aldrich, St Louis, MO) coated dishes and incubated at
37 C in a 5% CO2 humidified incubator.
For shear stress experiments, human umbilical vein ECs were seeded on human
fibronectin (Corning Lasne, Belgium) coated slides at a density of 500,000
cells/slide and let to grow for 3 days. The day of the experiment, the slide
containing the cell monolayers was inserted in a parallel plate flow chamber
designed in-house, the chamber was connected to a perfusion system containing a
media reservoir and a peristaltic pump (Cole Parmer, Antwerpen, Belgium). ECs
were exposed to laminar flow at a defined shear stress of 15 dyn cm 2 for 4 h for
protein extraction or 24 h for RNA extraction. For each experiments cells were
cultured in static condition. As negative control for NICD generation, cells were
treated with 50 mM DAPT or DMSO (vehicle) from 24 h prior exposure to shear
stress until the end of the experiment.
For Western blotting, RIPA buffer (Thermo Scientific, Bremen, Germany) was
used to extract proteins, supplemented by a cocktail of protease and phosphatase
inhibitors (Roche, Vilvoorde, Belgium). Protein separation was performed under
reducing conditions on NuPAGE gel 3–8% Tris-Acetate (Thermo Scientific,
Bremen, Germany). Proteins were transferred to a to a nitrocellulose membrane.
5% milk was used as blocking buffer for 1 h followed by incubation with primary
antibody in TBST 5% BSA overnight at 4 C or room temperature. After washing in
TBST, the membrane was incubated with secondary antibody for 1 h at room
temperature and signal was detected with Pierce ECL Western Blotting Substrate
(Thermofisher Scientific, Waltham, MA). Images were cropped and assembled with
ImageJ software. NICD was detected with rabbit anti-cleaved Notch1 antibody
(#4147, Cell Signaling Technology, Danvers, MA, 1:1,000). Rabbit anti-b-actin
(#4970, Cell Signaling Technology, 1:2,000) was used as loading control.
For reverse transcription quantitative PCR (RT-qPCR), isolation of the total
RNA was performed using TRIzol reagent (Invitrogen Life Technologies, Carlsbad,
CA), and cDNA was synthetized with High-Capacity cDNA Reverse Transcription
Kit (Thermofisher Scientific, Waltham, MA). RT-qPCR was performed with an
ABI 7500HT fast real-time PCR System (Applied Biosystems, Foster City, CA)
using SYBR Select Master Mix (Thermofisher Scientific, Waltham, MA). Selected
genes: HES1 (NM_005524.3), HEY1 (NM_012258.3), HEY2 (NM_012259.2), JAG1
(NM_000214.2) and NOTCH1 (NM_017617.3). HPRT1 (NM_000194.2) was used
for normalization.
To analyse the effect of Alendronate on bone endothelium, primary bone ECs
from wild-type mice were isolated and cultured following a protocol described
earlier8. Cultures were maintained and passaged minimum twice before the
experiment. Cells were treated with Alendronate (1 mM) for 8 h and subsequently
lysed to isolate RNA and perform qPCR as described before.
Statistics. All biological parameters are presented as mean±s.d. and counting
data as mean±s.e.m. The significance of difference in the mean values was
determined using two-tailed Student’s t test unless otherwise mentioned. Po0.05
was considered significant. All calculations were performed using GraphPad Prism
software. No randomization or blinding was used, and no animals were excluded
from analysis. Sample sizes were selected on the basis of previous experiments.
Several independent experiments were performed to guarantee reproducibility of
findings.
Data availability. All relevant data are presented in the manuscript and the
supplementary file and available from the authors upon request.
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